​A new study led by ACS researchers shows prostate cancer incidence rates increased in 11 of 50 countries, mostly located in Africa, Asia, Latin America, the Caribbean, and Central and Eastern Europe. Also, prostate cancer mortality trends climbed in nine of the 59 countries examined. In contrast, prostate cancer mortality declined in most high-income countries. The findings are published in the journal European Urology.​

Prostate cancer is the second most commonly diagnosed cancer and the fifth leading cause of cancer death among men worldwide, with over 1,460,000 estimated cases and 396,000 deaths. By 2040, the prostate cancer burden is predicted to increase to approximately 2.4 million cases and 712,000 deaths solely due to the aging and growth of the population.​

“The decline in prostate cancer mortality in most high-income countries reflects advances in early detection and treatment,” said Elizabeth Schafer, associate scientist, surveillance and health equity science at the American Cancer Society and lead author of the study. “However, the availability of these advances is limited in many low- and middle-income countries, such as parts of Africa, Asia, Latin America, and the Caribbean, which are experiencing increasing incidence and mortality rates.”

Other ACS researchers contributing to the study include Dr. Hyuna Sung, Dr. William Dahut, and senior author Dr. Ahmedin Jemal.

Like and share the ACS post on X about this news.